Candriam SCA’s Phathom Pharmaceuticals PHAT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-63,778	Closed	-$419K	–	836
2023 Q1	$419K	Sell	63,778 -19,579	-23%	-$129K	﹤0.01%	810
2022 Q4	$935K	Sell	83,357 -28,678	-26%	-$322K	0.01%	707
2022 Q3	$1.24M	Buy	+112,035	New	+$1.24M	0.01%	671